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Iron Status and Reproduction in US Women: National
Health and Nutrition Examination Survey, 1999-2006
Elizabeth M. Miller*
Department of Anthropology, University of South Florida, Tampa, Florida, United States of America

Abstract
Women experience significant changes in iron status throughout their reproductive lifespans. While this is evident in
regions with high rates of malnutrition and infectious disease, the extent of reproductive-related changes is less well known
in countries with low rates of iron deficiency anemia, such as the United States. The goal of this study is determine the
relationship between women’s reproductive variables (pregnancy, parity, currently breastfeeding, regular menstruation,
hormonal contraceptive use, and age at menarche) and iron status (hemoglobin, ferritin, transferrin receptor, and %
transferrin saturation) using an anthropological framework for interpreting the results. Data from women aged 18–49 were
taken from the 1999–2006 US NHANES, a nationally representative cross-sectional sample of US women. Using multiple
imputation and complex survey statistics, women’s reproductive variables were regressed against indicators of iron status.
Pregnant women had significantly poorer iron status, by most indicators, than non-pregnant women. All biomarkers
demonstrated significantly lower iron levels with increasing parity. Women who were having regular periods had iron
indicators that suggested decreased iron levels, while women who used hormonal contraceptives had iron indicators that
suggested increased iron levels. Despite relatively good iron status and widespread availability of iron-rich foods in the US,
women still exhibit patterns of iron depletion across several reproductive variables of interest. These results contribute to an
ecological approach to iron status that seeks to understand variation in iron status, with the hopes that appropriate,
population-specific recommendations can be developed to improve women’s health.
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blood. Menstrual blood loss has been associated with poorer
indicators of iron status [16–18], although this perspective is
controversial [19]. Fittingly, the use of hormonal contraceptive,
which is generally associated with lighter menstrual periods, is
associated with better indicators of iron status than in women who
do not use hormonal contraceptives [10,17]. Breastfeeding is also
associated with lower dietary iron needs [20,21] due to low levels
of iron in breast milk and lactational amenorrhea [22–25],
particularly in undernourished populations.
The National Health and Nutrition Examination Survey
(NHANES) offers a unique opportunity to investigate markers of
iron status across a broad cross-section of reproductive-aged US
women. Compared to the global population, the United States has
low rates of iron-deficiency anemia; however, it does appear that
reproduction-related iron depletion can occur, particularly in
pregnant women [26] and African American women [12]. This
study will investigate the relationship between reproductive
variables and markers of iron status using a biological anthropology framework. Specifically, it will explore how pregnancy, parity,
breastfeeding, menstruation, hormonal contraceptive use, and
menarche are associated with four indicators of iron status:

Introduction
Globally, reproductively-active women are at risk of irondeficiency anemia, which causes significant morbidity and
mortality [1,2]. The effects of low iron in women can have broad
global effects on their physical and cognitive capabilities as well as
specific effects on perinatal outcomes and infant health [3,4].
During pregnancy, iron is allocated to the fetus to a high degree,
particularly in the later trimesters [5,6]. This can lead to maternal
and fetal iron deficiency anemia, particularly in women with poor
iron status pre-pregnancy [4,7–9]. There is also evidence that this
can affect women across their reproductive careers: a growing
body of literature suggests that increasing parity is associated with
decreased indicators of iron status and greater likelihood of irondeficiency anemia [10–14]. While pregnancy depletes maternal
iron stores, after birth women have relatively low iron needs that
allows for repletion of iron stores before the next pregnancy [14].
When inter-birth intervals are short or when dietary iron is
insufficient, parity-related maternal iron depletion can result
[14,15].
Iron status has also been implicated in other aspects of women’s
reproduction, mainly attributed to the loss of iron via menstrual
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All n = 6603 (except transferrin receptor).
The n for the imputed mean for transferrin receptor is 3295; based on 2003–2006 survey years only.
All variables were available in original data set, so no 95% CI were generated by PROC MIANALYZE.
doi:10.1371/journal.pone.0112216.t001
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Table 1. Weighted descriptive statistics for study variables for women aged 18–49 who participated in the NHANES physical examination during 1999–2006, before and after
multiple imputation of missing values.
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hemoglobin, ferritin, transferrin receptor, and percent transferrin
saturation. This research will test the following hypotheses:

in the physical examination between 1999 and 2006, rates of
missing data were fairly high (see Table 1). Therefore, the current
study uses a multiple imputation method to correct for missing
responses and increase available sample size.

N

1) Women will show differences in iron status depending on their
current and past reproductive history. This hypothesis leads to
three predictions: a) Pregnant women will have lower iron
status than women who are not pregnant; b) Women who are
currently breastfeeding will have iron indicators that indicate
post-pregnancy iron recovery; and c) Increasing parity
(reproductive history) will be negatively associated with
indicators of iron status.
2) Women will experience short- and long-term effects of
menstruation on iron status. This hypothesis leads to two
predictions: a) Regularly menstruating women will have iron
indicators that indicate lower iron status; and b) Earlier age at
menarche will be associated with lower iron status.

Variable selection
Iron status. NHANES 1999–2006 has multiple variables
relating to iron status. Information relating to laboratory analysis
of iron status variables are available in the NHANES documentation on the CDC website. All continuous variables were left as
untransformed linear variables for analysis.
Found in red blood cells, hemoglobin is the main oxygentransporting protein in the body. Each hemoglobin molecule
contains one iron ion. Around 70% of the body’s iron is located in
hemoglobin. Hemoglobin levels are used to diagnose irondeficiency anemia, with values of ,12–12.5 g/dL generally
considered anemic in women [29], although can vary by
pregnancy status [3]. In the NHANES, hemoglobin was measured
as part of the complete blood count using the Coulter HMX
Hematology Analyzer [30–33]. Hemoglobin levels (g/dL) are
available for all children and adults who completed the physical
examination [30–33].
Ferritin is an iron-storage protein that is indirectly used as a
measure of iron levels in the body. Ferritin levels of ,12 ng/mL
are considered indicative of iron deficiency [29]. Ferritin levels
(ng/mL) are available for all adults and children from survey years
1999–2002 and in reproductive aged-women (12–49 years) in
survey years 2003–2006 [30–33]. Two different assays were used
to measure ferritin across data years: in years 1999–2003 BioRad
Laboratories’ two-site immunoradiometric assay kit was used,
while in 2004 and later years the Roche/Hitachi immunoturbidity
assay was used. The Roche/Hitachi method gives a higher ferritin
estimate than the BioRad assay, and must be normalized using a
derived piecewise linear equation [34]. While the 2003 data were
normalized to the 2004 data prior to release, investigators that use
the 1999–2002 data with later releases, including the current
study, must adjust the earlier values using provided equations [34].
Ferritin levels are increased during acute-phase inflammation [35],
so C-reactive protein (CRP) should be included in multivariate
models as a control variable.
Transferrin receptor is a carrier protein for transferrin,
providing transportation for iron into cells and helping maintain
iron homeostasis in the body. Transferrin receptor is upregulated
in the case of low body iron in order to help maintain intracellular
iron levels, and is frequently elevated in pregnancy [36–38].
Previous research has indicated that the cutoff for iron
deficiency for transferrin receptor in reproductive-aged women is
. 5.33 mg/L [39]. In the NHANES, serum transferrin receptor
was measured via immunoturbidity assay using Roche kits on the
Hitachi Mod P clinical analyzer [32,33]. Serum transferrin
receptor (mg/L) was available for all women aged 12–49 years
in survey years 2003–2006, but was only available for pregnant
women in survey years 1999–2002 [30–33]. While multiple
imputation would theoretically replace the missing data in the
earlier survey years, in practice multiple imputation of all 8 years
lead to biased data and models that would not converge.
Therefore, the decision was made to perform analyses on
transferrin receptor for 2003–2006 only, and impute the missing
data only in those years.
Percent transferrin saturation is a measure of the total body iron
that is bound to transferrin, which is a blood protein that binds to
and controls the release of the body’s iron. Percent transferrin
saturation was calculated using the formula: serum iron/total ironbinding capacity x 100%. Serum iron and total iron-binding

N

The US NHANES offers an opportunity to examine several
indicators of iron status in reproductive-aged women. Hemoglobin, an iron-containing oxygen carrier protein in red blood cells, is
the most common iron indicator used to diagnose anemia. Low
hemoglobin is diagnostic of anemia (the lowered ability of the
blood to carry oxygen) but cannot necessarily distinguish between
iron deficiency anemia and other causes of anemia. Serum ferritin,
an iron storage protein, correlates well with global iron stores
(except in the presence of inflammation). Low serum ferritin is
especially useful in distinguishing between iron deficiency anemia
and other forms of anemia [27]. Percent transferrin saturation is
the percent iron bound to transferrin (an iron carrier protein), and
is also a measure of iron deficiency. Finally, serum transferrin
receptor binds to transferrin in order to transfer iron into cells.
Transferrin receptor increases during iron deficiency as the body’s
tissues attempt to increase intercellular iron concentration, and
can be used to distinguish iron deficiency anemia from other forms
of anemia even when inflammation is present. These four
measurements offer similar, but slightly different, perspectives on
iron status and can provide insight into the dynamics of iron
physiology in reproductive-aged women.

Subjects and Methods
Ethics statement
This study was originally approved by the National Center for
Health Statistics Research Ethics Review Board, and participants
underwent informed consent before data collection. Because the
current study is a secondary analysis of de-identified data, the
University of South Florida Institutional Review Board determined that this research is not human subjects research and thus
not subject to review.

Sample design
The NHANES is a US-representative survey conducted by the
Centers for Disease Control and Prevention (CDC), which has
been collecting data on a two-year continuous basis since 1999.
The goal of the NHANES is to collect health and nutrition-related
data on the general US population. NHANES uses a complex
sample design in which participants are weighted according to
geographic and census information, and certain groups (such as
pregnant women) are oversampled for analytical purposes [28].
Adding to the complexity of the data, not all NHANES
participants who took part in the interview decided to take part
in the physical examination. There are also considerable missing
data, particularly in the reproductive health questionnaire.
Although 6603 women between the ages of 18 and 49 participated
PLOS ONE | www.plosone.org
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In multiple imputation, several imputed data sets are generated,
and the desired statistical analysis is performed on each one. After
analysis, the results from each imputed set are averaged across
variables to help control for the variance introduced by the
imputation process [40,41].
Multiple imputation proceeds through three steps: 1) the
generation of the MI data sets, which generates likely values for
missing variables based on available data; 2) complex survey
regression analyses based on the MI data sets; and 3) the synthesis
of the imputed data sets and regression analyses, which combines
the imputed results and reports the variability introduced by the
imputation process [41,42]. The MI process was performed in
SAS 9.3 (SAS Institute, Inc., Cary, North Carolina). Statistical
significance was assessed at a = 0.05 (two-sided).
The multiple imputation of data sets was performed using
PROC MI in SAS. In SAS, PROC MI uses a Markov chain
Monte Carlo method that assumes arbitrary missing data and
multivariate normality. Standard usage of MI data sets suggests
that at least 5 imputed data sets should be used, although this
number may be higher for data sets with more missing data [43].
Due to the high levels of missing values for some variables in the
data set, n = 50 imputations were performed in this analysis. For
50 imputations, reliability estimates for each variable were above
95%. All variables mentioned above were included in the
imputation analysis, but income variables were dropped from
regression analysis because they were not statistically significant
and had no biological rationale for being included as a control
variable.
A special mention should be made of dichotomous variables in
MI procedures. Imputed dichotomous variables are not dichotomous themselves, but instead range as a proportion between 0 and
1. Some practitioners round the imputed fractions to the nearest 0
or 1; however, this practice leads to biased estimates of these
variables [44]. Analysis of a variety of methods for handling
dichotomous variables suggests that for the majority of cases,
imputed fractions should be left alone for regression analysis [45].
Therefore, imputed dichotomous variables in this study were left
as-is for analysis.
Analysis of imputed data sets was performed using PROC
SURVEYMEANS for descriptive statistics and PROC SURVEYREG for linear regression. All survey analyses (descriptive
and regression) were adjusted using NHANES-provided variables
for strata and cluster, and the adjusted 8-year sample weight
described above (or the 4-year sample weight for the transferrin
receptor model). The imputed data sets were added to the model
as part of the domain statement. This allows the analyses to be
performed on each imputed data set.
For the PROC SURVEYREG analyses, four models were run
with each iron biomarker (hemoglobin, ferritin, transferrin
receptor, and % transferring saturation) as dependent variables.
Independent variables for each model were as follows: current
pregnancy, parity, currently breastfeeding, currently using contraceptive pills, ever used contraceptive pills, having regular
periods in the past 12 months, and age at menarche. All models
were adjusted for ethnicity (with white ethnicity as the reference
variable), survey release years (with 1999–2000 as the reference
variable except the transferrin receptor model, which used 2003–
2004 as the reference variable), BMI, CRP, age, and 24-hour
recall of dietary iron intake.
To complement MI analysis, it is recommended that an analysis
of all complete cases (cases with no missing data) be performed in
order to assess potential areas of bias, either in the complete case
or in the multiple imputation [46]. In this study, complete case
analyses were performed for each model using PROC SUR-

capacity were measured using automated AAII-25 colorimetric
method modified to be performed on the Alpkem Flow Solutions
3000 system [30–33]. Percent transferrin saturation was available
in 1999–2000 for men and women of all ages and in 2001–2006
for women between the ages of 12 and 59 years [30–33]. Percent
transferrin saturation is considered deficient when values fall below
16% [29].
Reproductive history variables. Reproduction-related variables are available for all women above the age of 12 in the
reproductive health questionnaire. Some reproductive variables
were constructed using more than one variable in order to
accurately represent the survey methods and the population’s
response. For all constructed reproductive variables, respondents
with missing values for both questions were left missing.
Pregnancy status was determined by the results of the urine
pregnancy test. A continuous parity variable was constructed
based on a combined variable, first by using a variable that asks if
women had ever been pregnant and for those that said yes, using
the number of reported live births. Women who had no
pregnancies were reported to have a parity of 0; for all others,
the reported live births were used as their parity value.
A dichotomous variable for currently breastfeeding women was
created using three variables: First, women who reported never
being pregnant were coded as not currently breastfeeding. Second,
women who had given birth within the past two years were asked
if they were currently breastfeeding; those that said yes were coded
as currently breastfeeding and those that said no were coded as not
currently breastfeeding. Finally, women who had reported giving
birth 2 or more years ago were coded as not currently
breastfeeding (the NHANES survey made the assumption during
data collection that women 2 or more years post birth were not
currently breastfeeding).
Two dichotomous variables for hormonal contraceptive use
were created: one, for current use of hormonal contraception, and
two, for using hormonal contraception at any point during the life
span.
Reported having regular menstrual periods over the previous 12
months was included as a dichotomous variable. To assess the
long-term effects of menstrual history, recalled age at menarche
was included as a continuous variable.
Control variables. Regression analyses were controlled for
the following variables: Age, CRP level, body mass index (BMI),
survey year, ethnicity, dietary iron intake from 24-hour recall, and
household income. Age, BMI, CRP, and dietary iron intake were
included as continuous variables. Yearly household income was
coded as dummy variables in $5000 increments, up to $75,000+.
Ethnicity was coded as dummy variables for Hispanic (including
Mexican Americans), non-Hispanic black and other, with nonHispanic white as the reference category. Survey year for each
two-year data-release period was included as dummy variables.
Eight-year examination sample weights were calculated using
the 4-year weight for survey years 1999–2002 and two-year
weights for 2003-2004 and 2005–2006. The 4-year weights were
multiplied by K and the 2-year weights were multiplied by J to
create the 8-year weight variable. To create the 4-year weights for
the transferrin receptor models for 2003–2004 and 2005–2006,
the 2-year examination sample weights were multiplied by K [28].

Statistical methods
Excluding individuals who have missing values from analysis
can lead to biased results [40,41]. Multiple imputation (MI) is a
statistical method for replacing missing variables in a data set.
Imputation models use a probability model on both complete and
missing data in a set to generate likely variables for missing values.
PLOS ONE | www.plosone.org
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VEYREG and was adjusted for examination weight, strata, and
cluster as described above. The subdomain for this analysis was
female exam participants ages 18–49. Descriptive statistics for the
non-imputed, original data were performed using PROC
SURVEYMEANS and the parameters described above.
The final step was performed using PROC MIANALYSIS.
This procedure synthesizes the results of the 50 imputed data sets,
providing summary means and adjusted variances for PROC
SURVEYMEANS, and summary parameter estimates and
adjusted variances for the results of PROCSURVEYREG. This
method also provides 95% confidence intervals for means and
parameter estimates. Using these three steps, results are adjusted
for both the multiple imputation process and the complex survey
design of NHANES.

Hispanic and non-Hispanic black women had significantly lower
% transferrin saturation than white women. Finally, % transferrin
saturation was significantly negatively associated with BMI and
CRP.

Discussion
Pregnancy had a clear effect on some, but not all, of the iron
status measures. Pregnancy was associated with lower levels of
hemoglobin and ferritin, indicating that iron availability to red
blood cells and iron storage is compromised during pregnancy.
This is a typical finding for pregnant women, as the fetus’s high
iron needs depletes mothers’ iron stores, particularly as pregnancy
progresses. Similarly, % transferrin saturation was lower in
pregnant women than non-pregnant women, but not significantly
so. Curiously, transferrin receptor levels were significantly lower in
pregnant women compared to non-pregnant women. As transferrin receptor is usually higher under conditions of low body iron,
this result is opposite of what would be predicted by previous
literature [36,37]. However, it may be an expected result in the
context of maternal-fetal iron transfer. Maternal physiology is
hypothesized to negotiate the allocation of resources between
maternal and fetal somatic needs, which may sometimes conflict
with fetal interests [48,49]. In the case of maternal-fetal iron
transfer, previous research suggests that fetal iron transfer has
priority over maintaining maternal iron stores [50], and that fetal
iron deficiency only occurs after maternal iron stores have been
severely compromised [51,52]. The current results suggest that
transferrin receptor may be downregulated during pregnancy in
an attempt to allocate iron away from the mother’s tissues and
toward the fetus. These results hint at a pregnancy iron transfer
system that depletes bodily iron during pregnancy in favor of fetal
iron stores, supporting previous findings. However, more research
is necessary to confirm the physiological mechanisms that may
underlie such a mechanism.
There were no significant effects of breastfeeding on any iron
status values. Unfortunately, analysis of this variable was
hampered by the low rate of breastfeeding in US women: only
2% of women reported that they were currently breastfeeding.
Replicating these findings in a population of women with higher
breastfeeding rates would better test the hypothesis that the
postpartum period is a time of iron repletion in reproducing
women.
These results provide evidence that postpartum iron repletion is
incomplete in US women, and has an additive negative effect with
each child. Increasing parity was found to have a small but
statistically significant impact on all indicators of iron status. These
results replicate parity-related maternal iron depletion findings in
developing countries with high rates of iron-deficiency anemia,
albeit with smaller statistical estimates [14]. Despite the relatively
good overall iron status of the US population, high-parity women
are vulnerable to poor iron status. This effect may be particularly
worrisome in high parity women who become pregnant [26].
The results show that having regular periods across the past 12
months is associated with lower iron stores than not having regular
periods, and that taking hormonal contraceptive pills is associated
with higher iron status. This seemingly points to the traditional
view that menstrual blood loss directly affects iron status, and that
contraception’s protective effect is due to lighter menstrual periods
while on the pill [16,17]. More recently, however, mouse models
have demonstrated a direct relationship between estrogen and iron
homeostasis [53,54]. Work on this relationship shows that that
estrogen directly inhibits the expression of hepcidin, a liverproduced peptide hormone that inhibits iron intake across the gut

Results
Descriptive statistics were performed on both the original data
sets and the imputed data sets using PROC SURVEYMEANS, to
adjust for the complex survey design (Table 1). The percent
missing data, derived from the total number of eligible women
(n = 6603), ranged from 0% to 32.7% depending on the variable of
interest. Graphs of the weighted association between iron
biomarkers and pregnancy are found in Figure 1 and iron
biomarkers and parity in Figure 2. Hemoglobin, ferritin, and %
transferrin saturation declined with increasing parity and was also
reduced in pregnant women. Transferrin receptor increased with
increasing parity, and was higher in non-pregnant women
compared to pregnant women. Table 2 shows the percentage of
women who fall below the cutoff value for each iron biomarker, as
well as the percentage of women considered iron deficient, as
defined by having two out of three values of hemoglobin, ferritin,
and % transferrin saturation below their respective cutoff values
[47].
Complete case results (estimates and p-values) for survey
regression for the four models is found in Table 3. In general,
there were between 60–65% complete cases for each model out of
the eligible women in the study population. Results do not appear
to differ significantly between the complete case results and the
imputed results, reported in Table 4.
Imputed estimates, 95% confidence intervals, and p-values for
each of the four models (analyzed using imputed values and
PROC SURVEYREG) can be found in Table 4. In the
hemoglobin model, there was a significant negative association
between pregnancy and hemoglobin, parity and hemoglobin, and
having regular periods and hemoglobin. In addition, white
American women had significantly higher hemoglobin than all
other ethnicities.
In the ferritin model, ferritin was significantly negatively
associated with pregnancy, parity, and having regular periods.
Ferritin was significantly positively associated with taking hormonal contraceptive. Several covariates were also statistically
significant. Hispanic women had significantly lower ferritin levels
while women whose ethnicity was given as ‘‘other’’ had
significantly higher ferritin levels. Ferritin was also significantly
positively associated with current age and CRP level.
Transferrin receptor levels were significantly positively associated with having regular menstrual periods and parity. Transferrin
receptor was negatively associated with pregnancy and taking
hormonal contraceptive pills. Transferrin receptor levels were also
significantly higher in non-Hispanic black women and in women
with higher BMIs.
Percent transferrin saturation was significantly negatively
associated with parity and having regular menstrual periods.
PLOS ONE | www.plosone.org
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Figure 1. Weighted (unimputed) means and ±1 standard error of the mean for measures of iron status by pregnancy status.
doi:10.1371/journal.pone.0112216.g001

menstruation-related iron homeostasis is tightly regulated, even in
women who continually menstruate throughout their reproductive
career.
The results showed significantly different measures of iron status
between ethnic groups in the US. Non-Hispanic white women had
higher hemoglobin compared to other groups, Hispanic women
had lower ferritin and % transferrin saturation compared to the
reference group (non-Hispanic white women), and non-Hispanic
black women had higher levels of transferrin receptor and lower %
transferrin saturation compared to the reference group. These
differences raise several questions. First, what is the normal range
of variation in US women? Why does it vary between groups, and
what are the factors that contribute to this reaction norm? Some
researchers suggest a lower threshold for iron-deficiency anemia
for African-American women [3], for example, but what drives
this difference? Second, it also demonstrates that there may be no
one picture of low iron status in women, and that each iron
indicator may offer a slightly different interpretation of the
physiological processes involved in the body’s response to low iron.
Further research would untangle the meaning of these different
pathways, particularly in the context of women’s reproduction.
Finally, it is worth investigating population-specific reproductive
outcomes due to poor iron status. There are well-known
consequences of maternal iron-deficiency anemia, including
preterm birth, low birth weight, increased maternal morbidity,

and is a regulator of iron homeostasis in the body [55]. When
estrogen is high, hepcidin is low and iron uptake into the body is
increased. The authors proposed that this is a mechanism to
regulate iron uptake across the menstrual cycle, and can explain
the higher level of iron in women who take hormonal contraceptives [55].
Despite the immediate impact of having regular periods and
using contraceptive pills on iron status, there appears to be no
long-term effects: history of contraceptive pill use and age at
menarche were not significantly associated with iron stores in this
population. It could be hypothesized that menstruation-related
iron loss should accumulate, particularly in a population who
spends a high proportion of their reproductive careers menstruating [56]. However, these results call into question the idea that
blood loss is the sole cause of altered iron stores in menstruating
women. This perspective has also been advanced by Clancy et al.
[19], who note that a thicker endometrium (and greater potential
menstrual blood loss) is actually associated with higher hemoglobin
in reproductive-aged Polish women. Contrary to established
wisdom, their work shows menstruation is associated with better,
not worse, iron status, and suggests that iron is a sensitive indicator
of reproductive condition. Rather than assume that menstrual
blood loss leads to anemia, a closer examination of the corelationship between hepcidin, iron absorption, estrogen, and
reproduction in women is warranted. It is more likely that
PLOS ONE | www.plosone.org
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Figure 2. Weighted (unimputed) means and ±1 standard error of the mean for measures of iron status by parity.
doi:10.1371/journal.pone.0112216.g002

increased risk of infant iron-deficiency, poor neurocognitive
development in infants, and others [4,7]. However, meta-analyses
indicate that most of these adverse outcomes (with the exception of
pre-term birth) are not consistent across studies [57]. Rather than
doubt the possibility of these adverse outcomes, an anthropological

approach would instead posit that there may be ecological
variation in the appearance of these outcomes. Instead, the
question becomes: who do these adverse outcomes happen to, and
why? Further work from an anthropological perspective may

Table 2. Non-imputed, weighted percentages of NHANES women who are below iron indicator cutoffs by pregnancy status (See
Table 1 for number of non-missing values in each category).

Hemoglobin (,12 g/dL)

Non-pregnant women

Pregnant women

6.9%

29.1%

Ferritin (,12 ng/mL)

10.9%

18.5%

Transferrin receptor (.5.33 mg/L)a

5.4%

5.7%

% Transferrin saturation (,16%)

29.7%

39.1%

% Iron deficientb

9.8%

25.4%

a

Percentages based on 2003–2006 survey years only.
Calculated based on percentage of women who had two of three values (hemoglobin, ferritin, and % transferrin saturation) below cutoff.
doi:10.1371/journal.pone.0112216.t002
b
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20.00010

Dietary iron intake (mg)

10.54

0.95

0.96

0.0017

20.087
20.00020

CRP (g/L)

Age (years)

0.11

0.55

0.0018

0.044

0.73

0.14

0.28

0.094

2005–2006

2.61

210.39

7.73

20.022

24.09

20.65

216.62

20.062

9.97

3.41

BMI (kg/m2)

0.70

219.94
22.27

0.11

20.033

0.0004

,0.0001

,0.0001

0.076

0.0032

0.69

0.59

0.78

0.0003

,0.0001

Estimate

0.14

2003–2004

2001–2002

20.47

Having regular periods

Age at menarche

Other

20.20
20.024

Ever use birth control

20.29

0.026

Current birth control use

21.06

20.034

Currently breastfeeding

Hispanic

0.037

Parity

Non-Hispanic black

21.02
20.081

Currently pregnant

Transferrin receptor model is based on survey years 2003–2006 only.
Reference category is white ethnicity.
Reference category is survey release year 1999–2000 (hemoglobin, ferritin, and % transferrin saturation models).
d
Reference category is survey release year 2003–2004 (transferrin receptor model only).
doi:10.1371/journal.pone.0112216.t003

c

b

a

Other Covariates

Survey Releasec,d

Ethnicity

b

Reproductive Status

p

0.7448

,0.0001

,0.0001

0.5819

0.9627

0.4303

0.0011

0.0711

0.9935

0.0355

0.3056

,0.0001

0.98

0.0108

0.5687

0.0026

,0.0001

p

20.013

0.040

22.34

20.27

0.025

0.41

20.22

21.85

22.84

21.49

20.070

21.22

20.042

1.44

20.98

20.66

20.58

Estimate

0.63

0.16

,0.0001

,0.0001

0.97

0.60

0.75

0.034

,0.0001

0.016

0.59

0.067

0.95

0.042

0.35

0.0002

0.48

p

R2 = 0.071

Estimate

n = 4245

n = 4252

n = 4255
R2 = 0.15

R2 = 0.095

% Transferrin Saturation

Ferritin

Hemoglobin

0.0043

20.00060

0.053

0.029

20.25

–

–

0.29

0.54

20.053

20.0051

0.013

20.00070

20.33

0.37

0.047

20.033

Estimate

R2 = 0.099

n = 2019

0.32

0.90

0.18

0.0002

0.0023

–

–

0.12

,0.0001

0.60

0.74

0.93

0.99

0.0001

0.14

0.17

0.74

p

Transferrin Receptora

Table 3. Weighted estimates and p-values for complete case survey regression models of hemoglobin, ferritin, % transferrin saturation, and transferrin receptor as dependent
variables, reproductive variables as independent variables, and ethnicity, survey release year, and other covariates as control variables.
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0.57

0.11

2005–2006

20.056, 0.17

20.0050, 0.0052

0.000067
20.0017

Age (years)

Dietary iron intake (mg)

20.0062, 0.0028

20.082, 0.017

0.00064
20.032

CRP (g/L)

20.0043, 0.0056

20.05, 0.28

0.057, 0.37

20.18, 0.18

20.49, 20.13

21.17, 20.98

20.35, 20.14

20.035, 0.011

20.37, 20.19

BMI (kg/m )

2

0.21

2003–2004

20.31

Other
20.0031

21.08

Non-Hispanic black

2001–2002

20.25

20.012

Age at menarche

Hispanic

0.057
20.28

Ever use birth control

Having regular periods

0.45

0.98

0.20

0.80

0.17

0.0077

0.97

0.0008

,0.0001

,0.0001

0.29

,0.0001

0.32

0.21

20.34, 0.19
20.20, 0.043

20.076

Currently breastfeeding

Current birth control use 20.077

,0.0001
0.0003

Parity

21.24, 20.99
20.10, 20.030

21.12
20.066

Currently pregnant

p

20.12

1.16

12.61

0.23

3.11

9.38

26.80

11.76

6.57

24.09

20.70

232.25

0.56

14.74

27.40

22.94

219.60

Estimate

b

p

20.37, 0.14

0.90, 1.41

7.49, 17.73

20.17, 0.62

22.18, 8.40

4.95, 13.81

212.06, 21.53

2.37, 21.16

20.27, 13.41

27.92, 20.26

0.37

,0.0001

,0.0001

0.26

0.25

,0.0001

0.012

0.014

0.060

0.036

0.26

,0.0001

21.91, 0.51

0.82

238.43, –26.08

0.0007

0.29

0.0003

24.36, 5.47

6.24, 23.23

221.12, 6.32

24.55, 21.34

227.03, 212.16 ,0.0001

95% CI

The n for the hemoglobin, ferritin, and % transferrin saturation model is 6603 (all years).
The n for the transferrin receptor model is 3295 (survey years 2003–2006 only).
c
Mean R2 of 50 imputations.
d
Reference category is white ethnicity.
e
Reference category is survey release year 1999–2000 (hemoglobin, ferritin, and % transferrin saturation models).
f
Reference category is survey release year 2003–2004 (transferrin receptor model only).
doi:10.1371/journal.pone.0112216.t004

a

Other Covariates

Survey Releasee,f

Ethnicityd

Reproductive Status

95% CI

R2 = 0.12c

R2 = 0.17c
Estimate

Ferritina

Hemoglobina

20.024

0.067

21.96

20.27

0.054

0.94

20.10

21.45

22.53

21.59

0.022

21.42

20.0058

1.18

20.95

20.62

20.58

,0.0001

0.0012

0.84

0.0025

0.99

0.067

0.44

,0.0001

0.36

p

20.067, 0.019

0.021, 0.11

22.43, 21.48

20.31, 20.22

21.00, 1.11

20.20, 2.08

21.17, 0.96

0.27

0.0046

,0.0001

,0.0001

0.92

0.11

0.85

22.89, 20.0058 0.049

23.34, 21.73

22.55, 20.63

20.20, 0.25

22.34, 20.50

21.08, 1.06

20.084, 2.45

23.38, 1.48

20.90, 20.34

21.84, 0.67

Estimate 95% CI

R2 = 0.093c

% Transferrin Saturationa

0.0024

20.0026

20.016

0.033

20.052

–

—

0.086

0.91

0.042

0.015

0.29

20.059

20.40

0.37

0.10

20.29

20.0063, 0.011

20.012, 0.0065

20.090, 0.057

0.025, 0.042

20.21, 0.10

–

—

20.15, 0.33

0.68, 1.14

20.13, 0.21

20.024, 0.053

0.068, 0.52

20.25, 0.13

20.57, 20.23

20.14, 0.88

0.052, 0.15

20.51, 20.057

Estimate 95% CI

R2 = 0.10c

Transferrin Receptorb

0.59

0.58

0.66

,0.0001

0.51

–

—

0.48

,0.0001

0.62

0.45

0.011

0.55

,0.0001

0.15

,0.0001

0.014

p

Table 4. Weighted estimates, 95% confidence intervals, and p-values for imputed survey regression models of hemoglobin, ferritin, % transferrin saturation, and transferrin
receptor as dependent variables, reproductive variables as independent variables, and ethnicity, survey release year, and other covariates as control variables.
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provide better insight into the ecology of iron use in women’s
reproduction.
One interesting finding in this study is that reported levels of
dietary iron intake in the current study were not significantly
associated with indicators of iron status in statistical analyses.
Interestingly, the reported dietary intake of iron in this sample of
women (13.73 mg/day) was lower than the recommended daily
intake of 18 mg/day for reproductive-aged women; however, rates
of iron deficiency were 9.8% in non-pregnant women and 25.4%
in pregnant women (Table 2). These results show that while
women in the US have clear reproductive-related changes in iron
status, low iron is considerably less prevalent in non-pregnant
women, despite their lower-than-recommended dietary intake.
When viewed through an anthropological framework, these
results challenge current interpretations of the variation in
women’s reproduction in several ways. First, rather than use cutoff levels that determine iron deficiency, this study instead
examined iron status as continuous variables, as is typical in
biological anthropology. Therefore, these results do not make
recommendations relating to supplementation or the avoidance of
reproductive-related low iron in the US. Rather, they are intended
to show associated patterns and to help identify potential future
research areas of interest to both anthropologists and nutritional
scientists. Second, although many of these results are statistically
significant, they may not all be biologically significant. For
example, the parity results, although significant, would require a
large number of children in most cases to find a biologically
meaningful effect. While this is uncommon among US women,
populations with higher fertility rates should be advised of parityrelated effects. Third, the results from this study challenge what is
considered a ‘‘normal’’ iron status in US women. These results
show evidence of reproduction-related changes in iron status in
US women despite the widespread availability of iron-rich foods
and supplements. Perhaps rather than viewing every case of low
iron during pregnancy as a problem in need of correction, low iron
should be viewed as a normal function of women’s pregnancy,
provided these women and their infants do not experience adverse
outcomes [58,59]. This falls in line with other research that
suggests that pregnant women should have lower cutoff thresholds
for anemia, and that these cutoffs may vary by ethnicity [3].
Finally, these results highlight the contradictory nature of
recommending supplementation while stating that some degree

of low iron is normal in reproducing women. To reconcile the
contradiction, it may be true that US women need iron
supplementation during their pregnancy, but might not need the
daily high doses of iron recommended by health officials. For
example, a meta-analysis of the literature has found that
intermittent iron supplementation prevents iron deficiency in
pregnant women as well as daily supplementation, with fewer
adverse effects [60]. The current results do suggest that certain
situations may require more attention to risk factors that might
require iron supplementation, such as very high parity women and
non-white women. By incorporating some tolerance of low iron as
‘‘normal,’’ and by understanding the ecological variation in iron
status between populations, supplementation recommendations
can help avoid under- and over-treating low iron in reproductiveaged women. These results can help point researchers to more
specific iron supplementation recommendations for pregnant and
non-pregnant women, both in the US and on the global stage.
There are several limitations to this study. First, these results are
limited by the data collection. The NHANES was not specifically
designed for a study of this nature, so data are limited and missing
in many cases. This was partially corrected by means of multiple
imputation, but the limitations on data between survey releases
could not be statistically overcome, particularly in the case of
transferrin receptor data. Similarly, there are limited types of
questions available in the survey, and not all questions of interest
could be asked using this data. For example, women’s interbirth
interval is a very important data point when considering the
pregnancy-depletion/postpartum-repletion cycle and parity-related iron depletion. Despite these limitations, these results offer
insight into the mechanisms of reproductive-related iron status in
US women and suggest future research into the mechanisms of
reproductive iron homeostasis.
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